Career history of Glenn A. Oclassen
Former positions of Glenn A. Oclassen
| Companies | Position | Start | End |
|---|---|---|---|
North American Clinical Dermatologic Society, Inc.
 North American Clinical Dermatologic Society, Inc. Miscellaneous Commercial ServicesCommercial Services North American Clinical Dermatologic Society, Inc. operates as a non-profit organization which provides clinical dermatology educational opportunities by arranging annual meetings with academic centers and societies worldwide. The company was founded by Charles A. Oclassen in 1959 and is headquartered in Springfield, PA. | Corporate Officer/Principal | 21/07/2009 | 13/11/2019 |
| Cutaneous Therapy Society, Inc. | Corporate Officer/Principal | 21/07/2009 | 13/11/2019 |
| VERRICA PHARMACEUTICALS INC. | Director/Board Member | 01/12/2015 | 13/11/2019 |
| Independent Dir/Board Member | 01/12/2015 | 13/11/2019 | |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | Director/Board Member | 30/01/2009 | 06/02/2009 |
Transcept Pharmaceuticals, Inc. (Old)
 Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA. | Founder | 01/01/2009 | 01/01/2009 |
| President | - | 01/01/2009 | |
| NextDerm, Inc. | Chairman | 01/01/1999 | 01/01/1999 |
| Founder | 01/01/1997 | 01/01/1999 | |
| President | - | 01/01/1999 | |
Oclassen Pharmaceuticals, Inc.
 Oclassen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets. | Chairman | 01/02/1997 | 01/02/1997 |
| Founder | 01/02/1997 | 01/02/1997 | |
| PharmaQuest Corp. | Chief Operating Officer | 01/01/1985 | 01/01/1985 |
| President | - | 01/01/1985 | |
| Peachtree Creek Consulting Group | Corporate Officer/Principal | 01/01/1984 | 01/01/1984 |
| ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ | - | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Glenn A. Oclassen
| San Diego State University | Undergraduate Degree |
Statistics
International
| United States | 16 |
Operational
| President | 5 |
| Director/Board Member | 4 |
| Corporate Officer/Principal | 4 |
Sectoral
| Health Technology | 8 |
| Consumer Non-Durables | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 13 |
|---|---|
Neutrogena Corp.
 Neutrogena Corp. Household/Personal CareConsumer Non-Durables Neutrogena Corp. manufactures and markets skin and hair care products. Its products include cleansers, acne, moisturizers, anti-aging, and cosmetics. The company was founded by Emanuel Stolaroff in 1930 and is headquartered in Los Angeles, CA. | Consumer Non-Durables |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA. | Health Technology |
Allergan Pharmaceuticals Ltd., Inc.
 Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Health Technology |
Oclassen Pharmaceuticals, Inc.
Oclassen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets. | Health Technology |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | Health Technology |
| Dermatology Foundation | |
North American Clinical Dermatologic Society, Inc.
North American Clinical Dermatologic Society, Inc. Miscellaneous Commercial ServicesCommercial Services North American Clinical Dermatologic Society, Inc. operates as a non-profit organization which provides clinical dermatology educational opportunities by arranging annual meetings with academic centers and societies worldwide. The company was founded by Charles A. Oclassen in 1959 and is headquartered in Springfield, PA. | Commercial Services |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
| NextDerm, Inc. | |
| PharmaQuest Corp. | |
| Peachtree Creek Consulting Group | |
| Cutaneous Therapy Society, Inc. |
- Stock Market
- Insiders
- Glenn A. Oclassen
- Experience
